Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2025-12-25 @ 12:13 AM
NCT ID:
NCT01664858
Eligibility Criteria:
Inclusion Criteria:
* Patient ≥30yrs
* Patient has suspected stable angina (CHD) that requires further investigation
* Has a defined risk of 10-90% (according to NICE guidelines CG95; 2010)
* Suitable for revascularisation if required
* Given informed written consent
Exclusion Criteria:
* Non-anginal chest pain
* Clinically unstable
* Previous MI or biomarker positive ACS
* Previous revascularisation with coronary artery bypass surgery or PCI
* Contraindication to CMR imaging (pacemaker, intra-orbital debris, intra-auricular implants, intracranial clips, severe claustrophobia)
* Contraindication to adenosine infusion (regular adenosine antagonist medication, significant reversible airways disease, second or third degree atrio-ventricular heart block, sino-atrial disease)
* Known adverse reaction to Adenosine or Gadolinium contrast agent
* Obesity (where body girth exceeds scanner diameter)
* Pregnancy or breast feeding
* Inability to give informed consent
* Known chronic renal failure (eGFR \<30mL/min/1.73m2)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Study:
NCT01664858
Study Brief:
Protocol Section:
NCT01664858